Seizures News - LARVOL Sigma

Seizures

Welcome, Profile Billing Logout

31 Mechanisms of Action

«1 2 3 4 5 678 9 10 11 12 »

||||||||||  lacosamide / Generic mfg.
Trial initiation date:  Study to Investigate Lacosamide as Add-on Therapy in Subjects ?4 Years to <17 Years of Age With Partial Onset Seizures (clinicaltrials.gov) -  Jun 27, 2014
P3, N=300, Ongoing,  Sponsor: UCB BIOSCIENCES, Inc.
Initiation date: Aug 2013 --> Nov 2013

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Dainippon, BIAL
New P2 trial:  A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093 (clinicaltrials.gov) -  Jun 24, 2014
P2, N=144, Completed,  Sponsor: Bial - Portela C S.A.

||||||||||  lacosamide / Generic mfg.
Trial initiation date:  A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. (clinicaltrials.gov) -  Jun 19, 2014
P2, N=50, Ongoing,  Sponsor: UCB Biosciences Inc.
Initiation date: Aug 2013 --> Nov 2013 Initiation date: Oct 2013 --> Feb 2014

|||||||||| Enrollment open: ANSeR- The Algorithm for Neonatal Seizure Recognition Study (clinicaltrials.gov) - Jun 5, 2014
P=N/A, N=408, Recruiting, Sponsor: University College Cork
Initiation date: Oct 2013 --> Feb 2014 Not yet recruiting --> Recruiting

||||||||||  phenytoin / Generic mfg., brivaracetam / Generic mfg.
Enrollment open:  Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) -  Jun 4, 2014
P2, N=50, Recruiting,  Sponsor: UCB BIOSCIENCES, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

||||||||||  phenytoin / Generic mfg., brivaracetam / Generic mfg.
Trial initiation date:  Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) -  Jun 4, 2014
P2, N=50, Not yet recruiting,  Sponsor: UCB BIOSCIENCES, Inc.
Not yet recruiting --> Recruiting Initiation date: May 2014 --> Jun 2014

||||||||||  Fycompa (perampanel) / Eisai, Catalyst Pharma
Trial primary completion date:  4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures (clinicaltrials.gov) -  Jun 3, 2014
P2, N=108, Active, not recruiting,  Sponsor: Eisai Inc.
Initiation date: May 2014 --> Jun 2014 Trial primary completion date: Mar 2014 --> Jun 2014

||||||||||  selurampanel (BGG492) / Novartis
New P2 trial:  Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) -  May 27, 2014
P2, N=77, Not yet recruiting,  Sponsor: Novartis Pharmaceuticals

||||||||||  phenobarbital / Generic mfg.
Trial completion date:  Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures (clinicaltrials.gov) -  May 26, 2014
P3, N=345, Active, not recruiting,  Sponsor: West-Ward Pharmaceutical
Trial primary completion date: Mar 2014 --> Jun 2014 Trial completion date: Dec 2013 --> Oct 2014

|||||||||| Review, Trial primary completion date: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - May 18, 2014
P=N/A, N=1200, Completed, Sponsor: Hôpital Armand Trousseau
Trial completion date: Dec 2013 --> Oct 2014 Trial primary completion date: Dec 2013 --> Mar 2014

|||||||||| Review, Trial completion date: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - May 18, 2014
P=N/A, N=1200, Completed, Sponsor: Hôpital Armand Trousseau
Trial primary completion date: Dec 2013 --> Mar 2014 Trial completion date: Dec 2013 --> Mar 2014

|||||||||| Review, Enrollment change: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - May 18, 2014
P=N/A, N=1200, Completed, Sponsor: Hôpital Armand Trousseau
Trial completion date: Dec 2013 --> Mar 2014 N=1000 --> 1200

|||||||||| Trial completion, Review: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - May 18, 2014
P=N/A, N=1200, Completed, Sponsor: Hôpital Armand Trousseau
N=1000 --> 1200 Recruiting --> Completed

|||||||||| Enrollment closed: WEPOD: Women With Epilepsy: Pregnancy Outcomes and Deliveries (clinicaltrials.gov) - May 15, 2014
P=N/A, N=200, Active, not recruiting, Sponsor: New York University School of Medicine
Recruiting --> Completed Recruiting --> Active, not recruiting

||||||||||  lacosamide / Generic mfg.
Trial primary completion date:  VITOBA: Vimpat (clinicaltrials.gov) -  May 15, 2014
P=N/A, N=576, Completed,  Sponsor: UCB Pharma GmbH
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2013 --> Jul 2013

||||||||||  lacosamide / Generic mfg.
Trial completion date:  VITOBA: Vimpat (clinicaltrials.gov) -  May 15, 2014
P=N/A, N=576, Completed,  Sponsor: UCB Pharma GmbH
Trial primary completion date: Jun 2013 --> Jul 2013 Trial completion date: Jun 2013 --> Jul 2013

||||||||||  topiramate XR / Generic mfg.
Trial primary completion date:  Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures (clinicaltrials.gov) -  May 14, 2014
P3, N=172, Completed,  Sponsor: Upsher-Smith Laboratories
Trial completion date: Jun 2013 --> Jul 2013 Trial primary completion date: Feb 2014 --> May 2014

||||||||||  topiramate XR / Generic mfg.
Trial completion:  Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures (clinicaltrials.gov) -  May 14, 2014
P3, N=172, Completed,  Sponsor: Upsher-Smith Laboratories
Trial primary completion date: Feb 2014 --> May 2014 Active, not recruiting --> Completed

|||||||||| Enrollment open, Surgery: Effect of Music Therapy on Cognitive Recovery (clinicaltrials.gov) - May 12, 2014
P=N/A, N=60, Recruiting, Sponsor: Seton Family of Hospitals
Active, not recruiting --> Completed Not yet recruiting --> Recruiting

||||||||||  sertraline / Generic mfg.
Trial completion:  NEST-T_1: Treatment Trial for Psychogenic Nonepileptic Seizures (clinicaltrials.gov) -  May 7, 2014
P4, N=38, Completed,  Sponsor: Rhode Island Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

||||||||||  clonazepam / Generic mfg., lorazepam / Generic mfg., clobazam / Generic mfg.
New P3 trial:  Clobazam Use in Epilepsia Partialis Continua - Pilot Study (clinicaltrials.gov) -  May 7, 2014
P3, N=18, Not yet recruiting,  Sponsor: The Cooper Health System

|||||||||| New P4 trial: Clinical Performance of Hydrogel vs. Silicone Hydrogel Contact Lenses (clinicaltrials.gov) - May 4, 2014
P4, N=60, Recruiting, Sponsor: Coopervision, Inc.

||||||||||  levetiracetam / Generic mfg.
Trial primary completion date:  An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (clinicaltrials.gov) -  May 4, 2014
P3, N=44, Active, not recruiting,  Sponsor: UCB, Inc.
Active, not recruiting --> Completed Trial primary completion date: Oct 2015 --> Jun 2016

||||||||||  levetiracetam / Generic mfg.
Trial completion date:  An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (clinicaltrials.gov) -  May 4, 2014
P3, N=44, Active, not recruiting,  Sponsor: UCB, Inc.
Trial primary completion date: Oct 2015 --> Jun 2016 Trial completion date: Oct 2015 --> Jun 2016

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Trial primary completion date:  A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (clinicaltrials.gov) -  May 1, 2014
P=N/A, N=254, Active, not recruiting,  Sponsor: Eisai Inc.
Trial completion date: Oct 2015 --> Jun 2016 Trial primary completion date: Feb 2014 --> Aug 2013

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Trial initiation date:  A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (clinicaltrials.gov) -  May 1, 2014
P=N/A, N=254, Active, not recruiting,  Sponsor: Eisai Inc.
Trial primary completion date: Feb 2014 --> Aug 2013 Initiation date: Apr 2012 --> Apr 2013

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Trial completion date:  A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (clinicaltrials.gov) -  May 1, 2014
P=N/A, N=254, Active, not recruiting,  Sponsor: Eisai Inc.
Initiation date: Apr 2012 --> Apr 2013 Trial completion date: Feb 2014 --> Jun 2014

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Enrollment change:  A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (clinicaltrials.gov) -  May 1, 2014
P=N/A, N=254, Active, not recruiting,  Sponsor: Eisai Inc.
Trial completion date: Feb 2014 --> Jun 2014 N=800 --> 254

||||||||||  Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Enrollment closed:  A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS) (clinicaltrials.gov) -  May 1, 2014
P=N/A, N=254, Active, not recruiting,  Sponsor: Eisai Inc.
N=800 --> 254 Recruiting --> Active, not recruiting

||||||||||  levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment closed:  Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures (clinicaltrials.gov) -  Apr 27, 2014
P4, N=340, Active, not recruiting,  Sponsor: UCB Korea Co. Ltd.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting

|||||||||| Trial suspension: HYBERNATUS: Evaluation of Therapeutic Hypothermia in Convulsive Status EPILEPTICUS in Adults in Intensive Care (clinicaltrials.gov) - Apr 21, 2014
P3, N=270, Suspended, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Active, not recruiting Recruiting --> Suspended

||||||||||  topiramate / Generic mfg.
Trial completion:  Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures (clinicaltrials.gov) -  Apr 13, 2014
P3, N=118, Completed,  Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting --> Suspended No longer recruiting --> Completed

|||||||||| Enrollment change: Acid Suppressing Drug Seizure Epidemiology Study (clinicaltrials.gov) - Apr 6, 2014
P0, N=534, Active, not recruiting, Sponsor: AstraZeneca
No longer recruiting --> Completed N=300000 --> 534

|||||||||| Trial completion: New Magnesium Sulphate Protocol for Pre-eclampsia (clinicaltrials.gov) - Apr 6, 2014
P3, N=240, Completed, Sponsor: Cairo University
N=300000 --> 534 Recruiting --> Completed

||||||||||  Fycompa (perampanel) / Eisai, Catalyst Pharma
Enrollment closed:  Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs (clinicaltrials.gov) -  Apr 6, 2014
P2, N=48, Active, not recruiting,  Sponsor: Eisai Inc.
Recruiting --> Completed Recruiting --> Active, not recruiting

||||||||||  Fycompa (perampanel) / Eisai, Catalyst Pharma
Enrollment closed:  A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures (clinicaltrials.gov) -  Apr 6, 2014
P3, N=165, Active, not recruiting,  Sponsor: Eisai Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting

|||||||||| Clinical: Prospective Study of Comparison Between the Modified Atkins Diet and Classic Ketogenic Diet for Intractable Childhood Epilepsy (clinicaltrials.gov) - Mar 30, 2014
P=N/A, N=78, Completed, Sponsor: Yonsei University

|||||||||| Biomarker, Trial completion: Biomarkers In Seizure To Predict Recurrence and Severe Outcomes (clinicaltrials.gov) - Mar 25, 2014
P=N/A, N=300, Completed, Sponsor: Bistro Study Group
Recruiting --> Active, not recruiting Recruiting --> Completed

|||||||||| Enrollment closed: Nonconvulsive Electrotherapy: a Proof-of-concept Trial (clinicaltrials.gov) - Mar 19, 2014
P1, N=16, Active, not recruiting, Sponsor: University of Maryland
Recruiting --> Completed Recruiting --> Active, not recruiting

||||||||||  phenytoin / Generic mfg., brivaracetam / Generic mfg.
New P2 trial:  Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) -  Mar 13, 2014
P2, N=50, Not yet recruiting,  Sponsor: UCB BIOSCIENCES, Inc.

||||||||||  levetiracetam / Generic mfg.
Enrollment change:  Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (clinicaltrials.gov) -  Mar 6, 2014
P4, N=52, Completed,  Sponsor: University of Cincinnati
Recruiting --> Active, not recruiting N=104 --> 52

||||||||||  levetiracetam / Generic mfg.
Trial completion:  Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (clinicaltrials.gov) -  Mar 6, 2014
P4, N=52, Completed,  Sponsor: University of Cincinnati
N=104 --> 52 Recruiting --> Completed

|||||||||| Trial completion: A Study for Treatment of Partial Seizures in Children (clinicaltrials.gov) - Feb 22, 2014
P3, N=50, Completed, Sponsor: Abbott
Recruiting --> Completed No longer recruiting --> Completed

|||||||||| Trial completion: Herpes Virus-6 and Epilepsy (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=45, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No longer recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion: RNS® System Feasibility Study (clinicaltrials.gov) - Feb 22, 2014
P2, N=70, Completed, Sponsor: NeuroPace
Recruiting --> Completed No longer recruiting --> Completed

|||||||||| Trial completion: Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity (clinicaltrials.gov) - Feb 22, 2014
P2, N=25, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
No longer recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures (clinicaltrials.gov) - Feb 22, 2014
P3, N=153, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Activating Effects of Sleep Deprivation on Synchronized MEG-EEG Recordings of Epilepsy Patients With Non-Diagnostic EEG (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=25, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  zonisamide / Generic mfg.
Trial completion, Monotherapy:  Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy (clinicaltrials.gov) -  Feb 22, 2014
P3, N=165, Completed,  Sponsor: Eisai Inc.
Recruiting --> Completed No longer recruiting --> Completed

|||||||||| Trial completion: ERSET: Early Surgical Intervention to Treat Epilepsy (clinicaltrials.gov) - Feb 22, 2014
P3, N=200, Completed, Sponsor: University of California, Los Angeles
No longer recruiting --> Completed Active, not recruiting --> Completed